IMOSIPA FUSA Trademark

Trademark Overview


On Thursday, October 24, 2024, a trademark application was filed for IMOSIPA FUSA with the United States Patent and Trademark Office. The USPTO has given the IMOSIPA FUSA trademark a serial number of 98817999. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, March 24, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The IMOSIPA FUSA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases
imosipa fusa

General Information


Serial Number98817999
Word MarkIMOSIPA FUSA
Filing DateThursday, October 24, 2024
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateMonday, March 24, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHuman pharmaceutical preparation for treating inflammatory diseases and autoimmune diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 24, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Thursday, October 24, 2024NEW APPLICATION ENTERED
Thursday, October 24, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 24, 2025ASSIGNED TO EXAMINER